Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort
-
Published:2023-09
Issue:9
Volume:11
Page:2701-2712.e2
-
ISSN:2213-2198
-
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
-
language:en
-
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice
Author:
Milger KatrinORCID,
Suhling Hendrik,
Skowasch Dirk,
Holtdirk Annette,
Kneidinger Nikolaus,
Behr Jürgen,
Timmermann Hartmut,
Schulz Christian,
Schmidt Olaf,
Ehmann Rainer,
Hamelmann Eckard,
Idzko Marco,
Taube Christian,
Lommatzsch Marek,
Buhl Roland,
Korn Stephanie
Subject
Immunology and Allergy
Reference32 articles.
1. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma;Bel;N Engl J Med,2014
2. Oral glucocorticoid–sparing effect of benralizumab in severe asthma;Nair;N Engl J Med,2017
3. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma;Rabe;N Engl J Med,2018
4. Mepolizumab treatment in patients with severe eosinophilic asthma;Ortega;N Engl J Med,2014
5. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial;FitzGerald;Lancet,2016
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献